General Info

Genlantis develops reagents for transfection, gene expression, Gene Silencing, RNA interference, primary cell culture and sample preparation in proteomics research. Located in San Diego, Calif., the company designs, develops and commercializes biological reagents for life scientists worldwide. Genlantis is also involved in the development of protein expression tools, as well as efficient delivery technologies for both in vitro and in vivo applications. It offers custom services that include protein expression and stable cell line generation. The company is a division of Gene Therapy Systems Inc. Gene Therapy Systems Inc.